Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy
- 31 August 2018
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 62 (23) , e1800392
Abstract
Starting from the 21st century, breast cancer can be classified as the most common invasive malignancy in women. Among the preventive or therapeutic strategies of breast cancer, combination therapy is the most promising approach. This mode of treatment of breast cancer concurrently maximizes efficacy, overcomes multidrug resistance, and minimizes harmful side effects caused by radiotherapy and chemotherapy alone. The risk of cancer can be reduced by supplementing diets with naturally occurring products known as phytochemicals. These phytochemicals have well‐defined roles in the management of every stage of breast carcinogenesis. In this review, the collective data of dietary phytochemicals used to sensitize breast cancer cells to therapeutic approaches are reported and their specific molecular targets through synergistic, additive, and potentiation effects are highlighted. The concept of combining natural agents with medicines to augment therapeutic responses creates an optimal modality, which may facilitate clinical applications of combination regimens in the future.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (105-2628-B-002-003-MY3, 105-2320-B-002-031-MY3.)
This publication has 92 references indexed in Scilit:
- Equol enhances tamoxifen’s anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cellsBMC Cancer, 2013
- Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9Molecules, 2013
- Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to CentchromanPLOS ONE, 2012
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cellsMolecular Cancer, 2010
- (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinomaBreast Cancer Research, 2010
- Triple-Negative Breast CancerThe Cancer Journal, 2010
- A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallateBritish Journal of Cancer, 2008
- Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor‐positive and HER2‐overexpressing human breast cancer cellsMolecular Carcinogenesis, 2007
- Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in miceCarcinogenesis, 2007